PRevention & Early Intervention In Mental Illness And Substance UsE (PREMISE CRE)
Funder
National Health and Medical Research Council
Funding Amount
$2,495,969.00
Summary
Substance use and mental disorders are among the leading causes of burden of disease in young people globally. Effective prevention and early intervention can reduce disease burden by halting, interrupting or delaying the onset and development of disorder. The PREMISE CRE will build the science to move the field from crisis, acute care and containment to prevention and early intervention, achieving a critical aim of the Australian Government’s program of reform in mental health and addiction.
Effects Of Latrepirdine On Beta Amyloid Clearance, Aggregation And Neurodegeneration In Alzheimer�s Disease
Funder
National Health and Medical Research Council
Funding Amount
$512,647.00
Summary
Alzheimer's disease (AD) is becoming more common with our growing aged population and currently no treatment exists that halts disease progress. The increasing health costs of AD underscore the need for development of any treatment that will slow or halt AD pathogenesis. By understanding the mechanisms of action of a drug [latrepirdine] that has recently shown some promise in phase II clinical trials, related drugs that are more specific and potent will be developed.